Skip to main content Accessibility help
×
Home

The effect of clozapine on adverse incidents in a low-secure challenging behaviour unit

  • M Dominic Beer (a1), Al Aditya Khan (a2) and Kalaanithi Ratnajothy (a3)

Abstract

Background: Previous studies have shown that as well as being an effective antipsychotic, clozapine reduced aggressive and violent incidents. Most of the studies measured the length of time the patients were on clozapine, or the dose of the clozapine when the effectiveness was evaluated.

Method: A retrospective audit was designed to see the effectiveness of clozapine in reducing incidents in a low-secure challenging behaviour unit. The number of incidents was calculated pre and post the date when clozapine serum level reached the therapeutic level of 0.35μg/l. Then, the number of incidents per month (incidents/month ratio) before and after reaching the therapeutic level was calculated.

Results: The number of incidents per month was reduced by over 75%. Before serum clozapine level reached 0.35μg/l the number of incidents/month/patient was 1.22 and after reaching 0.35μg/l, it was 0.26 (p=0.004).

Conclusions: The use of clozapine reduced the number of adverse incidents by 75%. The monitoring of serum levels was found to be clinically useful.

Copyright

Corresponding author

Correspondence to: Dr M.D. Beer, Bracton Centre, Oxleas NHS Trust, Bracton Lane, Dartford, Kent DA2 7AF, UK. E-mail: Dominic.Beer@oxleas.nhs.uk

References

Hide All
Alvir, J.M.J., Lieberman, J.A., Safferman, A.Z., Schwimmer, J.L. and Schaaf, J.A. (1993) Clozapine-induced agranulocytosis – incidence and risk factors in the United States. New England Journal of Medicine. 329(3): 162167.
Department of Health (2002a) Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care. London: HMSO.
Department of Health (2002b) Schizophrenia: Atypical Antipsychotics. Health Technology Assessment. London: HMSO.
Glazer, W.M. and Dickson, R.A. (1998) Clozapine reduces violence and persistent aggression in schizophrenia. The Journal of Clinical Psychiatry. 59(3): 814.
Hector, R.I. (1998) The use of clozapine in the treatment of aggressive schizophrenia. Canadian Journal of Psychiatry. 43(5): 466472.
Kilian, J.G., Kerr, K., Lawrence, C. and Celermajer, D.S. (1999) Myocarditis and cardiomyopathy associated with clozapine. Lancet. 354: 19411945.
Perry, P.J., Miller, D.D., Arndt, S.V. and Cadoret, R.J. (1991) Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients. American Journal of Psychiatry. 148(10): 231235.
Rabinowitz, J., Avnon, M. and Rosenberg, V. (1996) Effect of clozapine on physical and verbal aggression. Schizophrenia Research. 22(3): 249255.
Spina, E., Avenoso, A. and Facciola, G. et al. (2000) Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics. Psychopharmacology. 148(1): 8389.
Spivak, B., Mester, R., Wittenberg, N., Maman, Z. and Weizman, A. (1997) Reduction of aggressiveness and impulsiveness during clozapine treatment in chronic neuroleptic-resistant schizophrenic patients. Clinical Neuropharmacology. 20(5): 442446.
Volavka, J. (1999) The effects of clozapine on aggression and substance abuse in schizophrenic patients. Journal of Clinical Psychiatry. 60(12): 4346.
Volavka, J., Czobor, P., Nolan, K., Sheitman, B., Lindenmayer, J.P., Citrome, L., McEvoy, J.P., Cooper, T.B. and Lieberman, J.A. (2004) Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol. Journal of Clinical Psychopharmacology. 24(2): 225228.

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed